In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sanofi-Aventis completes Symbion acquisition

This article was originally published in Scrip

Executive Summary

Sanofi-Aventis has completed the A$560 million ($481 million) acquisition of Australia's Symbion Consumer from Primary Health Care. The move is expected to help the French company expand its nutraceuticals business in the Asia-Pacific region (Scrip Online, July 22nd, 2008). Symbion Consumer, part of Symbion Health, manufactures, markets and distributes nutraceuticals and other over-the-counter products throughout Australia and New Zealand. Sanofi-Aventis will consolidate Symbion Consumer sales from September 1st. Primary Health Care bought Symbion Health for more than A$2 billion in May.


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts